Talk:Celgene

This article is rated Start-class on Wikipedia's content assessment scale.
It is of interest to the following WikiProjects:

Companies Mid‑importance

This article is within the scope of WikiProject Companies, a collaborative effort to improve the coverage of companies on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.CompaniesWikipedia:WikiProject CompaniesTemplate:WikiProject Companiescompany articles

Mid This article has been rated as Mid-importance on the project's importance scale.

WikiProject Companies To-do:

Here are some tasks awaiting attention:

Article requests : Wikipedia:Requested articles/Business and economics/Companies
Assess : Category:Unassessed company articles
Copyedit : Category:Company articles needing attention
Infobox : Category:Company articles needing infoboxes
Maintain : Portal:Companies
Stubs : Help expand stub articles located at Category:Company stubs
Other :
- Tag company articles with the {{portal|Companies}} template
- Tag company talk pages with the {{WikiProject Companies}} project banner
- Answer requests for comments

New Jersey Low‑importance

	New Jersey portal This article is part of WikiProject New Jersey, an effort to create, expand, and improve New Jersey–related articles to Wikipedia feature-quality standard. Please join in the discussion.New JerseyWikipedia:WikiProject New JerseyTemplate:WikiProject New JerseyNew Jersey articles
Low	This article has been rated as Low-importance on the project's importance scale.

Pharmacology Low‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Low	This article has been rated as Low-importance on the project's importance scale.

Untitled

Celgene is one of the more promising biotech companies. It has revenue streams that are expected to increase in the coming years and new drugs in its pipeline. I was surprised to find so little information on it's Wikipedia page. I have started the process of augmenting this page. But because I discovered Celgene as an investor, most of what I know comes from its reported financial documents and from its website. I invite those from the medical and the scientific communities who know something about Celgene to add to this page. --RandomWalker 18:10, 25 June 2006 (UTC)[reply]

Fair use rationale for Image:Celgene-logo.jpg

Image:Celgene-logo.jpg is being used on this article. I notice the image page specifies that the image is being used under fair use but there is no explanation or rationale as to why its use in this Wikipedia article constitutes fair use. In addition to the boilerplate fair use template, you must also write out on the image description page a specific explanation or rationale for why using this image in each article is consistent with fair use.

Please go to the image description page and edit it to include a fair use rationale. Using one of the templates at Wikipedia:Fair use rationale guideline is an easy way to insure that your image is in compliance with Wikipedia policy, but remember that you must complete the template. Do not simply insert a blank template on an image page.

If there is other fair use media, consider checking that you have specified the fair use rationale on the other images used on this page. Note that any fair use images lacking such an explanation can be deleted one week after being tagged, as described on criteria for speedy deletion. If you have any questions please ask them at the Media copyright questions page. Thank you.

BetacommandBot (talk) 20:05, 13 February 2008 (UTC)[reply]

External links modified

Hello fellow Wikipedians,

I have just modified 3 external links on Celgene. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:

When you have finished reviewing my changes, you may follow the instructions on the template below to fix any issues with the URLs.

This message was posted before February 2018. After February 2018, "External links modified" talk page sections are no longer generated or monitored by InternetArchiveBot. No special action is required regarding these talk page notices, other than regular verification using the archive tool instructions below. Editors have permission to delete these "External links modified" talk page sections if they want to de-clutter talk pages, but see the RfC before doing mass systematic removals. This message is updated dynamically through the template {{source check}} (last update: 5 June 2024).

If you have discovered URLs which were erroneously considered dead by the bot, you can report them with this tool.
If you found an error with any archives or the URLs themselves, you can fix them with this tool.

Cheers.—InternetArchiveBot (Report bug) 18:37, 1 August 2017 (UTC)[reply]

SEC Form 10-K

Here's the SEC Form10-K, which contains a comprehensive report on the company.

https://www.sec.gov/Archives/edgar/data/816284/000081628419000014/0000816284-19-000014-index.htm
SEC Accession No. 0000816284-19-000014
Filing Date 2019-02-26
Documents 147
Period of Report 2018-12-31
CIK: 0000816284

10-K 1 a2018123110-k.htm 10-K
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2018
CELGENE CORPORATION

ITEM 1. BUSINESS

Celgene Corporation, together with its subsidiaries (collectively “we,” “our,” “us,” “Celgene” or the “Company”), is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. Celgene Corporation was incorporated in the State of Delaware in 1986.

[and on for 150 pages]

--Nbauman (talk) 00:04, 2 October 2020 (UTC)[reply]

Congressional hearings on price hikes of revlimid and copaxone

The big news in Sep. 2020 was the congressional hearings which investigated, most prominently, the rise in price of revlimid from $215 to $763 a dose. These hearings were widely covered in all the news media.

https://www.statnews.com/2020/09/30/democrats-drug-pricing-celgene-teva/
‘You just got better at making money’: Democrats blast Celgene, Teva for price hikes detailed in internal documents
By Nicholas Florko
STAT
September 30, 2020

WASHINGTON — A handful of newly elected Democrats, including Rashida Tlaib of Michigan, Ayanna Pressley of Massachusetts and Katie Porter of California put drug industry CEOs on the defensive Wednesday like they’ve never been before.

--Nbauman (talk) 00:14, 2 October 2020 (UTC)[reply]